n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea has been researched along with Cancer, Second Primary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Latour, M; Demidem, A; Madelmont, JC; Morvan, D; Papon, J | 1 |
1 other study(ies) available for n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Cancer, Second Primary
Article | Year |
---|---|
Cystemustine induces redifferentiation of primary tumors and confers protection against secondary tumor growth in a melanoma murine model.
Topics: Animals; Antineoplastic Agents; Cell Differentiation; Cell Division; Dose-Response Relationship, Drug; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasms, Second Primary; Nitrosourea Compounds; Nuclear Magnetic Resonance, Biomolecular; Tumor Cells, Cultured | 2001 |